Br J Psychiatry. 1988 Apr;152:470-6. doi: 10.1192/bjp.152.4.470.
Of 49 schizophrenic patients followed up 12 months after their first admission to hospital, only about 45% had experienced no relapse and had no schizophrenic symptoms; a poorer outcome was more often found in Feighner positive than Feighner negative schizophrenic patients. The patients' overall level of unemployment had more than doubled to 51%. In patients whose acute episodes responded to treatment, pimozide taken once weekly as maintenance therapy was as effective as intramuscular flupenthixol decanoate, but tardive dyskinesia appeared in two patients receiving weekly pimozide; the repeat psychometric assessment at 12 months found modest improvements, i.e. no evidence of intellectual decline, in Matrices, Block Design, and Digit Copying tests. Forty per cent of relatives still showed significant psychological distress, which correlated with patients' schizophrenic symptoms, and the relatives' social functioning remained poorer than that of a normal community sample.
在49例首次入院后随访12个月的精神分裂症患者中,只有约45%未复发且无精神分裂症症状;与费格纳阴性精神分裂症患者相比,费格纳阳性患者的预后更差。患者的总体失业率增加了一倍多,达到51%。在急性发作对治疗有反应的患者中,每周服用一次匹莫齐特作为维持治疗与肌肉注射癸酸氟奋乃静效果相同,但接受每周一次匹莫齐特治疗的两名患者出现了迟发性运动障碍;12个月时的重复心理测评发现,在矩阵、积木设计和数字复制测试中,有适度改善,即没有智力下降的迹象。40%的亲属仍表现出明显的心理困扰,这与患者的精神分裂症症状相关,亲属的社会功能仍比正常社区样本差。